Trails Edge Capital Partners, LP
Source: SEC Form 13F · as of Mar 2026Trails Edge Capital Partners, LP holds 17 biotech & pharma companies tracked by BioSniper, totaling $328.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$328.0M
| Company | Shares | Value |
|---|---|---|
| PCVXVaxcyte, Inc. | 662,470 | $38.5M |
| XENEXenon Pharmaceuticals Inc. | 640,000 | $37.2M |
| DFTXDefinium Therapeutics Inc. | 1,738,110 | $32.9M |
| MIRMMirum Pharmaceuticals, Inc. | 333,312 | $30.8M |
| NRIXNurix Therapeutics, Inc. | 1,743,220 | $27.0M |
| RVMDREVOLUTION MEDICINES, INC. | 245,000 | $23.8M |
| RCUSArcus Biosciences, Inc. | 1,047,935 | $22.6M |
| IMCRImmunocore Holdings plc | 682,597 | $20.6M |
| CYTKCYTOKINETICS INC | 300,000 | $19.8M |
| SNDXSyndax Pharmaceuticals Inc | 701,821 | $16.4M |
| FDMT4D Molecular Therapeutics, Inc. | 1,302,917 | $12.1M |
| XFORX4 Pharmaceuticals, Inc | 2,571,478 | $10.6M |
| IMVTImmunovant, Inc. | 414,054 | $10.3M |
| DSGNDesign Therapeutics, Inc. | 852,013 | $9.1M |
| NERVMinerva Neurosciences, Inc. | 1,419,000 | $8.5M |
| IPSCCentury Therapeutics, Inc. | 2,449,993 | $5.5M |
| IRDOpus Genetics, Inc. | 500,000 | $2.3M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.